Is Genomic Medicine Failing Minority Patients?

Monday, July 23, 2018

Cancer Therapy Advisor, by Bryant Furlow

The development of highly predictive and prognostic molecular biomarkers is key to realizing the promise of precision oncology, informing patient risk stratification, clinical decision-making, and treatment response monitoring, for example. As high-throughput genetic sequencing moves into the clinic, fully realizing the promise of precision oncology will hinge on research into the clinical implications of various genomic aberrations for patients from all racial and ethnic backgrounds. Read more.